Article FDA Thank You FDA updates guidance on developing drugs for Covid-19, replacing pandemic-era version
Agency IQ
DECEMBER 1, 2023
Furthermore, the guidance offered a list of updated clinical outcome measures and offered insight on FDA’s evolving view of decentralized clinical trials and the use of real-world data to supplement trials. Lastly, the revised guidance briefly discussed trials meant to assess drugs intended for prevention of Covid-19.
Let's personalize your content